“Epilepsy 90–80–70”: The Intersectoral Global Action Plan on epilepsy and other neurological disorders (2022–2031)

Epilepsy is one of the oldest known nervous system disorders and imposes enormous physical, psychological, social and economic burden on individuals, families and countries due to misunderstanding and stigmatization. These problems are most relevant for developing countries, where up to 85 % of epilepsy patients live. Despite the fact that it is a treatable and preventable disorder, there is a lack of adequate public awareness and understanding of the problems of epilepsy. This article is devoted to the Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) 2022–2031, adopted on 27 May 2022 at the 150th session of WHO’s Executive Board. It provides data on the public and medical importance of epilepsy, the history of the joint initiatives of WHO, the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) aimed at reducing the burden of epilepsy on society and improving public knowledge about neurological disorders. The key provisions of the Intersectoral Global Action Plan on epilepsy and other neurological disorders 2022–2031 are announced. The Epilepsy 90–80–70 cascade target, launched by ILAE and IBE, is presented to inspire decades of action and significantly improve care and treatment for all people living with epilepsy worldwide. The final section is devoted to the evolution of epileptology at Almazov National Medical Research Centre, its present and its prospects.

1. Chen Z, Rollo B, Antonic-Baker A, et al. New era of personalised epilepsy management. BMJ. 2020; 371:m3658. DOI:10.1136/bmj.m3658.

2. Karlov VA. Epilepsy in children and adult women and men. A guide for doctors. 2nd ed. Moscow: BINOM; 2019. P. 896. In Russian

3. Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017; 88(3):296–303. DOI: 10.1212/WNL.0000000000003509.

4. Shova NI, Mikhailov VA, Odintsova GV, et al. The Modern View on the Problem of Formation of Suicidal Behavior in Patients with a Pharmacoresistance Form of Epilepsy in the Postoperative Period (Review). Translational Medicine. 2019; 6(2):5–11. In Russian DOI: 10.18705/2311-4495-2019-6-2-5-11.

5. Mikhalovska-Karlova EP. Epilepsy and society: a new model of attitudes. Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova. 2014; 114(4–2):76–81. In Russian

6. Odintsova GV, Nesterova SV. Peculiarities of family functioning of women of reproductive age with epilepsy and migraine. Modern Problems of Science and Education. 2018; 5:39. In Russian

7. Thurman DJ, Begley CE, Carpio A, et al. The primary prevention of epilepsy: A report of the Prevention Task Force of the International League Against Epilepsy. Epilepsia. 2018; 59(5):905–914. DOI: 10.1111/epi.14068.

8. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(5):459–480. DOI: 10.1016/S1474-4422(18)30499-X.

9. World Health Organization. (‎2019)‎. Epilepsy: a public health imperative: summary. World Health Organization. In Russian https://iris.who.int/handle/10665/325444 (2019)

10. Krasko AS, Mikhailova NF, Dengina NO et al. The history of cognition and stigmatization of epilepsy patients. Healthcare. 2023; 3:16–23].

11.